Medopad gets $28M to connect patients and providers with mobile, AI tools

Artificial intelligence healthcare technology company Medopad has just landed $28 million in a Series A funding round with lead investments from China's NWS Holdings. But the company announced that its goal is to raise $120 million in the next few months. This funding comes after Medopad struck a series of 15 trade deals with Chinese firms, collectively worth more than $140 million (100 million pounds). Medopad was a member of the trade delegation that the UK recently sent to Beijing and Shanghai. "We now have several amazing strategic investors in the business, which is a great achievement for us as we gear for significant growth and scale our business," Dan Vahdat, CEO of Medopad, said in a statement.